BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12483277)

  • 1. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma.
    Camp R; Lind DS; Hemming AW
    J Hepatobiliary Pancreat Surg; 2002; 9(4):519-21. PubMed ID: 12483277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual indication for central pancreatectomy--late pancreatic metastasis of ocular malignant melanoma.
    Dumitraşcu T; Dima S; Popescu C; Gheonea DI; Ciurea T; Saftoiu A; Popescu I
    Chirurgia (Bucur); 2008; 103(4):479-85. PubMed ID: 18780624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
    Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
    J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variates of survival in metastatic uveal melanoma.
    Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
    J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma: natural history and treatment options for metastatic disease.
    Wöll E; Bedikian A; Legha SS
    Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
    Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
    Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate in the treatment of metastatic uveal melanoma--first experiences.
    Berger TG; Dieckmann D; Efferth T; Schultz ES; Funk JO; Baur A; Schuler G
    Oncol Rep; 2005 Dec; 14(6):1599-603. PubMed ID: 16273263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie.
    Mariani P; Piperno-Neumann S; Servois V; Berry MG; Dorval T; Plancher C; Couturier J; Levy-Gabriel C; Lumbroso-Le Rouic L; Desjardins L; Salmon RJ
    Eur J Surg Oncol; 2009 Nov; 35(11):1192-7. PubMed ID: 19329272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-to-adult living donor liver transplantation for malignant metastatic melanoma to the liver.
    Zhao J; Yan LN; Li B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):329-32. PubMed ID: 20525564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of metastatic melanoma confined to the liver.
    Papachristou DN; Fortner JJ
    Int Surg; 1983; 68(2):145-8. PubMed ID: 6885293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
    O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
    Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.
    Pachera S; Yokoyama Y; Nishio H; Oda K; Ebata T; Igami T; Abe T; Shingu Y; Nagino M
    J Hepatobiliary Pancreat Surg; 2009; 16(5):692-8. PubMed ID: 19267257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiorgan resection (including the pancreas) for metastasis of cutaneous malignant melanoma.
    Belágyi T; Zsoldos P; Makay R; Issekutz A; Oláh A
    JOP; 2006 Mar; 7(2):234-40. PubMed ID: 16525211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    Lewis KD; Robinson WA; McCarter M; Pearlman N; O'Day SJ; Anderson C; Amatruda TT; Baron A; Zeng C; Becker M; Dollarhide S; Matijevich K; Gonzalez R
    J Clin Oncol; 2006 Jul; 24(19):3157-63. PubMed ID: 16809738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic uveal melanoma: is there a role for conventional chemotherapy? - A single center study based on 58 patients.
    Pons F; Plana M; Caminal JM; Pera J; Fernandes I; Perez J; Garcia-Del-Muro X; Marcoval J; Penin R; Fabra A; Piulats JM
    Melanoma Res; 2011 Jun; 21(3):217-22. PubMed ID: 21467954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surgery in treatment of stage IV melanoma.
    Young SE; Martinez SR; Essner R
    J Surg Oncol; 2006 Sep; 94(4):344-51. PubMed ID: 16917867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of uveal melanoma patients after surgery for liver metastases.
    Frenkel S; Nir I; Hendler K; Lotem M; Eid A; Jurim O; Pe'er J
    Br J Ophthalmol; 2009 Aug; 93(8):1042-6. PubMed ID: 19429579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
    Bedikian AY; Millward M; Pehamberger H; Conry R; Gore M; Trefzer U; Pavlick AC; DeConti R; Hersh EM; Hersey P; Kirkwood JM; Haluska FG;
    J Clin Oncol; 2006 Oct; 24(29):4738-45. PubMed ID: 16966688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection in the popliteal fossa for metastatic melanoma.
    Marone U; Caracò C; Chiofalo MG; Botti G; Mozzillo N
    World J Surg Oncol; 2007 Jan; 5():8. PubMed ID: 17239242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.